200
Participants
Start Date
September 1, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
December 1, 2026
CorFlow Controlled Flow Infusion System - CoFI™
The CorFlow CoFI™ System is intended to assess the dynamic microvascular resistance and to treat microvascular obstruction in the coronary vasculature of patients following PCI with stent placement.
Lead Sponsor
CorFlow Therapeutics AG
INDUSTRY